|The Future for MLI|
With the full weight of the ABPI behind MLI and whilst maintaining the deterrent effect for the pharmaceutical industry, other opportunities now present themselves to expand the company.
Much of the work completed so far has brought us closer to health authorities, NHS Trusts and research ethics committees. We have been invited to assist in the training of REC members on a number of occasions providing the ideal platform to promote the best interests of the industry.
We are now being asked by European companies to assist in training and investigations.
"Early detection saves money - ignoring suspicion is costly".